Abstract:Objective: Disordered metabolism of estrogen is believed to play a significant role in endometrial carcinogenesis. Recently, a number of studies have been conducted to identify the role of estrogen-related gene polymorphism in endometrial cancer risk, generating conflicting conclusions. This meta-analysis aimed to assess the association between genetic polymorphisms involving estrogen metabolic enzymes and endometrial cancer risk.Methods: A systematic search of 6 databases was conducted. Fourteen studies on the association of COMT (catechol-O-methyltransferase) Val158Met, CYP1B1 Leu432Val, and CYP1B1 Asn453Ser polymorphisms with endometrial cancer risk were identified, enrolling a total of 4283 cancer cases and 7094 controls. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the relationship.Results: In CYP1B1 Leu432Val(rs1056836) analysis, the heterozygous genotype (CG) demonstrated an increased risk for endometrial cancer (Val/Leu vs Leu/Leu: pooled OR, 1.11; 95% CI, 1.01-1.23; P = 0.039; I-2 = 10.5%; (Val/Val + Val/Leu) vs Leu/Leu: pooled OR, 1.19; 95% CI, 1.03-1.38; P = 0.017; I-2 = 54.7%). As for CYP1B1 Asn453Ser(rs1800440) polymorphism, a decreased risk was observed in G allele compared with A allele (Ser vs Asn: pooled OR, 0.82; 95% CI, 0.72-0.94; P = 0.005; I-2 = 0.0%), and heterozygous genotype also showed a decreased risk compared with normal genotype (Ser/Asn vs Asn/Asn: pooled OR, 0.81; 95% CI, 0.69-0.95; P = 0.011; I-2 = 0.0%). As for COMT Val158Met (rs4680) polymorphism, the heterogeneous genotype showed a decreased risk for endometrial cancer compared with the common homogenous genotype in a fixed-effect model in Asian population (Met/Val vs Val/Val: pooled OR, 0.83; 95% CI, 0.70-0.98; P = 0.033; I-2 = 29.2%), whereas no positive results are found in other subgroups or models.Conclusions: COMT Val158Met was seen to show a decreased risk for endometrial cancer in Asian population. CYP1B1 Leu432Val and Asn453Ser polymorphisms demonstrated an increased and decreased risk for endometrial cancer, respectively. Further large and comprehensive studies in various populations with more detailed individual data are needed to confirm our findings.

Expression of Cytochrome P450 1B1 and Catechol-O-Methyltransferase in Breast Tissue and Their Associations with Breast Cancer Risk

Cytochrome P450 1B1 and Catechol-O-methyltransferase Genetic Polymorphisms and Breast Cancer Risk in Chinese Women: Results from the Shanghai Breast Cancer Study and a Meta-Analysis.

CYP2E1 T7632A and 9-Bp Insertion Polymorphisms and Colorectal Cancer Risk: a Meta-Analysis Based on 4,592 Cases and 5,918 Controls

Relation between single nucleotide polymorphism in estrogen-metabolizing genes COMT, CYP17 and breast cancer risk among Chinese women

[Association Between Genetic Polymorphisms of Metabolic Enzymes and Susceptibility of Colorectal Cancer].

Catechol-O-Methyltransferase And Cytochrome P-450 1b1 Polymorphisms And Endometrial Cancer Risk A Meta-Analysis

RRM1, TUBB3, TOP2A, CYP19A1, CYP2D6: Difference Between Mrna and Protein Expression in Predicting Prognosis of Breast Cancer Patients

[A Case-Control Study on the Association Between Genetic Polymorphisms of Metabolic Enzymes and the Risk of Colorectal Cancer].

A Multigenic Study on Breast Cancer Risk Associated with Genetic Polymorphisms of ER Alpha , COMT and CYP19 Gene in BRCA1/BRCA2 Negative Shanghai Women with Early Onset Breast Cancer or Affected Relatives

Genetic Polymorphisms in Estrogen-Metabolizing Genes and Breast Cancer Survival

Estrogen down regulates COMT transcription via promoter DNA methylation in human breast cancer cells

ATL: A Meta-analysis

Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study

[Prevalence of Val158Met Polymorphism in COMT Gene on Non-Brca1/2 Hereditary Breast Cancer].

Polymorphisms inCYP1A1 and breast carcinoma risk in a population-based case-control study of Chinese women

Contribution of Catechol-O-Methyltransferase Val158met Polymorphism to Endometrial Cancer Risk in Postmenopausal Women: A Meta-Analysis

Cytochrome P450 1A1 (CYP1A1) T3801C and A2455G Polymorphisms in Breast Cancer Risk: a Meta-Analysis

Association between the COMT Val158Met polymorphism and risk of cancer: evidence from 99 case-control studies.

Association of CYP2C19*3 Gene Polymorphism with Breast Cancer in Chinese Women.

Differences in cytochrome P450 2C19 (CYP2C19) expression in adjacent normal and tumor tissues in Chinese cancer patients.

Lack of Association Between the COMT Rs4680 Polymorphism and Ovarian Cancer Risk: Evidence from a Meta-analysis of 3,940 Individuals